Animal sciences & veterinary medicine |
|
|
|
|
Preparation of outer membrane vesicles from rabbit Bordetella bronchiseptica and their protein composition analysis |
Li NAN1(),Ye’e HUANG2,Chenwen XIAO2,Zhipeng WANG2,Qiang WEI2,Quan’an JI2,Ke LI2,Yan LIU2(),Guolian BAO2() |
1.College of Chemistry and Life Sciences, Zhejiang Normal University, Jinhua 321000, Zhejiang, China 2.Institute of Animal Husbandry and Veterinary Medicine, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China |
|
|
Abstract This study aimed to establish the optimal preparation method of outer membrane vesicles (OMVs) from rabbit Bordetella bronchiseptica (Bb). The FX-1 strain of rabbit Bb was used as the research object. Centrifugal ultrafiltration and ultrasonication were compared, and followed by the optimization of the preparation technics, such as culture time, antibiotic addition and filtering method. The physical and chemical properties of OMVs were examined with transmission electron microscope (TEM), scanning electron microscope (SEM) and nanoparticle tracking analysis (NTA), etc. The protein compositions were analysed with Bradford protein quantification, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). The results showed that centrifugal ultrafiltration was a better preparation method of OMVs, and the optimum culture time, cefalexin concentration and filtering method were 18 h, 64 μg/mL and filtration though 0.45 μm membrane once, respectively. The OMVs showed a spherical shape with the diameter of 127.83 nm±0.68 nm, containing a range of proteins associated with virulence and infection mechanisms. This preparation technique could significantly promote the production of OMVs, which making industrial production possible. Furthermore, analysis of the protein composition lays a foundation for novel subunit vaccine research and development.
|
Received: 19 May 2020
Published: 25 April 2021
|
|
Corresponding Authors:
Yan LIU,Guolian BAO
E-mail: nanlio@163.com;35792191@qq.com;baoguolian@163.com
|
|
Cite this article:
Li NAN,Ye’e HUANG,Chenwen XIAO,Zhipeng WANG,Qiang WEI,Quan’an JI,Ke LI,Yan LIU,Guolian BAO. Preparation of outer membrane vesicles from rabbit Bordetella bronchiseptica and their protein composition analysis. Journal of Zhejiang University (Agriculture and Life Sciences), 2021, 47(2): 251-260.
URL:
http://www.zjujournals.com/agr/10.3785/j.issn.1008-9209.2020.05.190 OR http://www.zjujournals.com/agr/Y2021/V47/I2/251
|
兔支气管败血波氏杆菌外膜囊泡的制备及其蛋白质成分分析
本研究旨在确立兔波氏杆菌外膜囊泡(outer membrane vesicles, OMVs)最佳制备工艺。以兔波氏杆菌毒力较强菌株FX-1为研究对象,筛选出制备OMVs的最优方法,并对培养时间、抗生素添加量及过滤方法进行逐一优化。采用透射电镜(transmission electron microscope, TEM)、扫描电镜(scanning electron microscope, SEM)、纳米颗粒追踪分析(nanoparticle tracking analysis, NTA)等方法分析OMVs的理化性质;采用考马斯亮蓝法(Bradford法)、十二烷基硫酸钠聚丙烯酰胺凝胶电泳(sodium dodecyl sulfate-polyacrylamide gel electrophoresis, SDS-PAGE)及液相色谱-串联质谱法(liquid chromatography-tandem mass spectrometry, LC-MS/MS)检测OMVs的蛋白质含量及组分。试验结果显示,超滤浓缩法是制备兔波氏杆菌OMVs的较适方法,采用该方法的最佳培养时间、头孢氨苄质量浓度和过滤方法分别为18 h、64 μg/mL和0.45 μm滤膜过滤一次。制得的OMVs呈纳米级球形囊泡,平均直径为127.83 nm±0.68 nm。蛋白质分析结果表明,OMVs上包含多种与兔波氏杆菌毒力和感染机制有关的蛋白质。该制备工艺能够显著提高兔波氏杆菌OMVs的产量,为其工业化生产提供了可能;对其结构和蛋白质成分的分析,为研发新型亚单位疫苗提供了科学依据。
关键词:
细菌外膜囊泡,
支气管败血波氏杆菌,
制备工艺,
蛋白质成分分析
|
|
[1] |
CHAMBERS J K, MATSUMOTO I, SHIBAHARA T, et al. An outbreak of fatal Bordetella bronchiseptica bronchopneumonia in puppies. Journal of Comparative Pathology, 2019,167:41-45. DOI:10.1016/j.jcpa.2018.12.002
doi: 10.1016/j.jcpa.2018.12.002
|
|
|
[2] |
YACOUB A T, KATAYAMA M, TRAN J, et al. Bordetella Bronchiseptica in the immunosuppressed population: a case series and review. Mediterranean Journal of Hematology and Infectious Diseases, 2014,6(1):e2014031. DOI:10.4084/MJHID.2014.031
doi: 10.4084/MJHID.2014.031
|
|
|
[3] |
ELLIS J A. How well do vaccines for Bordetella bronchiseptica work in dogs?A critical review of the literature1977—2014. The Veterinary Journal, 2015,204(1):5-16. DOI:10.1016/j.tvjl.2015.02.006
doi: 10.1016/j.tvjl.2015.02.006
|
|
|
[4] |
ROIER S, ZINGL F G, CAKAR F, et al. Bacterial outer membrane vesicle biogenesis: a new mechanism and its implications. Microbial Cell, 2016,3(6):257-259. DOI:10.15698/mic2016.06.508
doi: 10.15698/mic2016.06.508
|
|
|
[5] |
ADRIANI R, MOUSAVI G S L, NAZARIAN S, et al. Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions. Vaccine, 2018,36(2):322-330. DOI:10.1016/j.vaccine.2017.09.00
doi: 10.1016/j.vaccine.2017.09.00
|
|
|
[6] |
FERNANDEZ-ROJAS M A, VACA S, REYES-LOPEZ M, et al. Outer membrane vesicles of Pasteurella multocida contain virulence factors. Microbiology Open, 2014,3(5):711-717. DOI:10.1002/mbo3.201
doi: 10.1002/mbo3.201
|
|
|
[7] |
BERLEMAN J E, ALLEN S, DANIELEWICZ M A, et al. The lethal cargo of Myxococcus xanthus outer membrane vesicles. Frontiers in Microbiology, 2014,5:474. DOI:10.3389/fmicb.2014.00474
doi: 10.3389/fmicb.2014.00474
|
|
|
[8] |
FLEETWOOD A J, LEE M K S, SINGLETON W, et al. Metabolic remodeling, inflammasome activation, and pyroptosis in macrophages stimulated by Porphyromonas gingivalis and its outer membrane vesicles. Frontiers in Celluar and Infection Microbiology, 2017,7:351. DOI:10.3389/fcimb.2017.00351
doi: 10.3389/fcimb.2017.00351
|
|
|
[9] |
ZARIRI A, BESKERS J, DE WATERBEEMD B VAN, et al. Meningococcal outer membrane vesicle composition-dependent activation of the innate immune response. Infection and Immunity, 2016,84(10):3024-3033. DOI:10.1128/IAI.00635-16
doi: 10.1128/IAI.00635-16
|
|
|
[10] |
CAI W, KESAVAN D K,WAN J, et al. Bacterial outer membrane vesicles, a potential vaccine candidate in interactions with host cells based. Diagnostic Pathology, 2018,13(1):95. DOI:10.1186/s13000-018-0768-y
doi: 10.1186/s13000-018-0768-y
|
|
|
[11] |
LEITNER D R, LICHTENEGGER S, TEMEL P, et al. A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles. Frontiers in Microbiology, 2015,6:823. DOI:10.3389/fmicb.2015.00823
doi: 10.3389/fmicb.2015.00823
|
|
|
[12] |
ACEVEDO R, FERNáNDEZ S, ZAYAS C, et al. Bacterial outer membrane vesicles and vaccine applications. Frontiers in Immunology, 2014,5:121. DOI:10.3389/fimmu.2014.00121
doi: 10.3389/fimmu.2014.00121
|
|
|
[13] |
ROSENTHAL J A, CHEN L, BAKER J L, et al. Pathogen like particles: biomimetic vaccine carriers engineered at the nanoscale. Current Opinion in Biotechnology, 2014,28(8):51-58. DOI:10.1016/j.copbio.2013.11.005
doi: 10.1016/j.copbio.2013.11.005
|
|
|
[14] |
ROIER S, FENNINGER J C, LEITNER D R, et al. Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles. International Journal of Medical Microbiology, 2013,303(5):247-256. DOI:10.1016/j.ijmm.2013.05.001
doi: 10.1016/j.ijmm.2013.05.001
|
|
|
[15] |
ROIER S, LEITNER D R, IWASHKIW J, et al. Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice. PLoS ONE, 2012,7(8):e42664. DOI:10.1371/journal.pone.0042664
doi: 10.1371/journal.pone.0042664
|
|
|
[16] |
KLIMENTOVá J, STULíK J. Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria. Microbiological Research, 2015,170:1-9. DOI:10.1016/j.micres.2014.09.006
doi: 10.1016/j.micres.2014.09.006
|
|
|
[17] |
GERRITZEN M J H, STANGOWEZ L, DE WATERBEEMD B VAN, et al. Continuous production of Neisseria meningitidis outer membrane vesicles. Applied Microbiology Biotechnology, 2019,103(23/24):9401-9410. DOI:10.1007/s00253-019-10163-z
doi: 10.1007/s00253-019-10163-z
|
|
|
[18] |
DEVIENNE K F, RADDI M S G. Screening for antimicrobial activity of natural products using a microplate photometer. Brazilian Journal of Microbiology, 2002,33(2):166-168. DOI:10.1590/S1517-83822002000200014
doi: 10.1590/S1517-83822002000200014
|
|
|
[19] |
ALVES N J, TURNER K B, MEDINTZ I L, et al. Emerging therapeutic delivery capabilities and challenges utilizing enzyme/protein packaged bacterial vesicles. Therapeutic Delivery, 2015,6(7):873-887. DOI:10.4155/tde.15.40
doi: 10.4155/tde.15.40
|
|
|
[20] |
GU L, MENG R, TANG Y T, et al. Toll-like receptor 4 signaling licenses the cytosolic transport of lipopolysaccharide from bacterial outer membrane vesicles. Shock, 2019,51(2):256-265. DOI:10.1097/SHK.0000000000001129
doi: 10.1097/SHK.0000000000001129
|
|
|
[21] |
FINGERMANN M, AVILA L, DE MARCO M B, et al. OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves. Human Vaccines and Immunotherapeutics, 2018,14(9):2208-2213. DOI:10.1080/21645515.2018.1490381
doi: 10.1080/21645515.2018.1490381
|
|
|
[22] |
ORMAZáBAL M, BARTEL E, GAILLARD M E, et al. Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles. Vaccine, 2014,32(46):6084-6090. DOI:10.1016/j.vaccine.2014.08.084
doi: 10.1016/j.vaccine.2014.08.084
|
|
|
[23] |
KIM O Y, PARK H T, DINH N T H, et al. Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response. Nature Communications, 2017,8(1):626. DOI:10.1038/s41467-017-00729-8
doi: 10.1038/s41467-017-00729-8
|
|
|
[24] |
LIU J, HSIEH C L, GELINCIK O, et al. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum. Journal of Proteomics, 2019,195:125-137. DOI:10.1016/j.jprot.2018.12.029
doi: 10.1016/j.jprot.2018.12.029
|
|
|
[25] |
GUJRATI V, KIM S, KIM S H, et al. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. ACS Nano, 2014,8(2):1525-1537. DOI:10.1021/nn405724x
doi: 10.1021/nn405724x
|
|
|
[26] |
MATTOO S, CHERRY J D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clinical Microbiology Reviews, 2005,18(2):326-382. DOI:10.1128/CMR.18.2.326-382.2005
doi: 10.1128/CMR.18.2.326-382.2005
|
|
|
[27] |
YOON H, ANSONG C, ADKINS J N, et al. Discovery of Salmonella virulence factors translocated via outer membrane vesicles to murine macrophages. Infection and Immunity, 2011,79(6):2182-2192. DOI:10.1128/CMR.18.2.326-382.2005
doi: 10.1128/CMR.18.2.326-382.2005
|
|
|
[28] |
BOTTERO D, ZURITA M E, GAILLARD M E, et al. Membrane vesicles derived from Bordetella bronchiseptica: active constituent of a new vaccine against infections caused by this pathogen. Applied and Environmental Microbiology, 2018,84(4):e01877-17. DOI:10.1128/AEM.01877-17
doi: 10.1128/AEM.01877-17
|
|
|
[29] |
LóPEZ-BOADO Y S, COBB L M, DEORA R. Bordetella bronchiseptica flagellin is a proinflammatory determinant for airway epithelial cells. Infection and Immunity, 2005,73(11):7525-7534. DOI:10.1128/IAI.73.11.7525-7534.2005
doi: 10.1128/IAI.73.11.7525-7534.2005
|
|
|
[30] |
LIU Y, CHEN H, WEI Q, et al. Immune efficacy of five novel recombinant Bordetella bronchiseptica proteins. BMC Veterinary Research, 2015,11:173. DOI:10.1186/s12917-015-0488-4
doi: 10.1186/s12917-015-0488-4
|
|
|
[31] |
ASENSIO C J, GAILLARD M E, MORENO G, et al. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate. Vaccine, 2011,29(8):1649-1656. DOI:10.1016/ j.vaccine.2010.12.068
doi: 10.1016/
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|